Today: 11 March 2026
Subscribe
Browse Category

Stock Market 3 December 2025

Shell Plc (SHEL) Stock on December 3, 2025: Adura JV, $3.5 Billion Buyback and Oil-Glut Jitters Shape the 2026 Outlook

Shell Plc (SHEL) Stock on December 3, 2025: Adura JV, $3.5 Billion Buyback and Oil-Glut Jitters Shape the 2026 Outlook

Shell plc closed at $73.96 in New York and 2,788.5p in London on December 2, 2025, near multi-year highs after reporting $5.4 billion in Q3 adjusted earnings and launching a $3.5 billion buyback. The stock is up 10–16% over the past year. Analysts cite oil glut forecasts for 2026 and softer crude prices as limiting further gains.
3 December 2025
···
Indian Rupee Breaches ₹90 Per US Dollar for the First Time: What’s Driving the Fall and How It Hits Your Wallet

Indian Rupee Breaches ₹90 Per US Dollar for the First Time: What’s Driving the Fall and How It Hits Your Wallet

The Indian rupee fell past ₹90 per US dollar for the first time on December 3, 2025, hitting lows near ₹90.20 in early trade. The currency has dropped about 5% this year, making it Asia’s worst performer in 2025 despite strong GDP growth. Analysts cite stalled India–US trade talks, US tariffs, trade deficits, capital outflows, and limited RBI intervention as key factors.
3 December 2025
Hindustan Unilever (HUL) Share Price Today: Demerger Record Date, Broker Targets and Outlook as of 3 December 2025

Hindustan Unilever (HUL) Share Price Today: Demerger Record Date, Broker Targets and Outlook as of 3 December 2025

Hindustan Unilever traded at ₹2,460–2,470 per share on 3 December, down 0.5% from the previous close, as investors awaited the 5 December record date for the spin-off of its ice-cream business into Kwality Wall’s (India) Ltd. The stock remains about 11% below its 52-week high, with one-year returns flat to slightly negative. Shareholders will receive one KWIL share for each HUL share held.
3 December 2025
··
Shriram Finance Share Price Today (3 Dec 2025): Top Loser After 40% Rally, MUFG Deal Buzz and 2026 Stock Forecast

Shriram Finance Share Price Today (3 Dec 2025): Top Loser After 40% Rally, MUFG Deal Buzz and 2026 Stock Forecast

Shriram Finance shares fell about 2% to ₹825.35 by early afternoon on December 3, 2025, after a three-month rally of roughly 42%. The stock remains near record highs, with a 52-week range of ₹493–872 and a market cap around ₹1.55 trillion. Q2 FY26 results showed net interest income up 11.8% year-on-year and profit after tax up 11.4% to ₹2,307.2 crore. The board declared an interim dividend of ₹4.80 per share.
3 December 2025
·
ICICI Bank Share Price Today: D‑SIB Status, Nifty Bank Rejig and Moody’s Call – What It All Means for the Stock in 2026

ICICI Bank Share Price Today: D‑SIB Status, Nifty Bank Rejig and Moody’s Call – What It All Means for the Stock in 2026

ICICI Bank traded near ₹1,386 in mid-day Mumbai trade on December 3, up about 1%. The Reserve Bank of India reaffirmed its status as a systemically important bank, requiring a 0.2% CET1 capital surcharge. Moody’s maintained a Baa3 rating with stable outlook, citing strong profitability and asset quality. Market capitalisation stood close to ₹9.9 trillion.
3 December 2025
·
BSE Ltd Share Price Today (3 December 2025): After a 61% Profit Jump, Is the Multi‑Bagger Rally Losing Steam or Just Pausing?

BSE Ltd Share Price Today (3 December 2025): After a 61% Profit Jump, Is the Multi‑Bagger Rally Losing Steam or Just Pausing?

BSE Ltd shares fell about 1.9% to ₹2,789 on 3 December, pausing after a sharp multi-year rally. The stock remains up nearly 89% over the past year and more than 4,400% in five years. Q2 FY26 net profit rose 61% year-on-year to about ₹558 crore, marking a tenth straight quarter of record revenue. Market capitalisation stands near ₹1.15 lakh crore.
3 December 2025
·
Sun Pharma Advanced Research (SPARC) Stock Soars After US Court Ruling on Sezaby PRV – What the 30% Two‑Day Rally on 3 December 2025 Really Means

Sun Pharma Advanced Research (SPARC) Stock Soars After US Court Ruling on Sezaby PRV – What the 30% Two‑Day Rally on 3 December 2025 Really Means

SPARC shares surged nearly 30% in two days after a US court restored a Priority Review Voucher for its neonatal seizure drug Sezaby. The stock hit ₹179.5 on 3 December 2025, with trading volume topping 70 million shares, far above average. Despite the rally, SPARC’s 12-month price remains down about 38%. The US government has 60 days to appeal the court’s decision.
3 December 2025
·
Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys Share Price Today (December 3, 2025): Q2 FY26 Results, ₹18,000-Crore Buyback, GST Demand and Stock Forecast

Infosys shares closed at ₹1,583 on the NSE December 3, up 1.4% despite declines in India’s benchmark indices. Trading volume reached about 6.7 million shares as investors processed a just-completed ₹18,000-crore buyback and a record-weak rupee. The Nifty IT index gained 1%, with Infosys turnover among the highest by value on the BSE. The stock remains over 20% below its 2024 high.
3 December 2025
···
HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank Share Price Today (3 December 2025): D‑SIB Capital Rules, RBI Penalty and 2026 Stock Forecast

HDFC Bank shares traded near ₹990 midday on 3 December 2025, little changed after recent profit-taking and strong quarterly earnings. The Reserve Bank of India reaffirmed HDFC Bank’s “too big to fail” status, requiring a 0.40% extra capital buffer. Trading volumes topped 27 million shares, well above the weekly average. Market capitalization stands at about ₹15.25 lakh crore.
3 December 2025
···
Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea Share Price Jumps on AGR Relief Buzz: Latest News, Analyst Targets and Outlook (3 December 2025)

Vodafone Idea shares rose 3.65% to ₹10.51 by midday on December 3, 2025, with volumes topping 800 million as speculation grew over government relief for AGR dues. The stock has rebounded nearly 80% since its August low, after the Supreme Court allowed a reassessment of dues and the government became the largest shareholder with a 48.99% stake in April.
3 December 2025
·
Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz

Stock Market Today 03.12.2025

Amanat Holdings PJSC reported 330.2% earnings growth year over year, driven by a one-off AED68.3M gain, raising its net profit margin to 24.1%. The S&P BSE Sensex rose 110 points to 85,216.95, while the NSE Nifty 50 gained 41 points to 26,027.15 amid rupee weakness and FII outflows. Bitcoin held near $93,000 as soft US data fueled Fed rate cut bets; Asian stocks traded mixed.
3 December 2025
·
Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas (CTAS) Stock on December 2, 2025: Institutions Buy the Dip as Analysts See Mid‑Teens Upside

Cintas Corporation closed at $184.19 on December 2, 2025, near its 52-week low and down about 17% over the past year, despite continued revenue growth and strong margins. Arrowstreet Capital, Panagora Asset Management, and Edgestream Partners have all increased their stakes in recent filings. Cintas’ market cap stands near $75 billion, with the stock trading at over 40 times trailing earnings.
3 December 2025
·
3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M Stock (MMM) Nears 52‑Week High: Q3 Earnings, PFAS Risks and 2026 Forecasts Explained

3M shares closed at $171.56 on December 2, 2025, near a four-year high and up about 31% over the past year. Technical models show short-term bullish momentum, but long-term forecasts from CoinCodex and StockScan project a possible decline to around $133 by 2026–2030. The company’s market cap stands at $91 billion with a dividend yield of 1.7%. Investors remain split over legal risks and recent gains.
3 December 2025
···
Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

Bristol-Myers Squibb (BMY) Stock Today: Celgene Lawsuit Shock, ASH 2025 Momentum and 2026 Forecasts

A U.S. judge on Dec. 1, 2025, revived a $6.7 billion lawsuit against Bristol-Myers Squibb over Celgene contingent value rights, sending BMY shares down 1.89% to $48.25. The stock marked its third straight loss, underperforming peers as legal risks weighed despite positive hematology data at ASH 2025. Market cap stood at about $98 billion. Trading volume was below average at 14.5 million shares.
3 December 2025
··
Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management (APO) Stock: December 2, 2025 News, Morgan Stanley Upgrade and 2026 Growth Outlook

Apollo Global Management shares closed at $132.08 on December 2, 2025, up 0.53%, with after-hours trading lifting the price to $132.80. The firm confirmed $908 billion in assets under management as of September 30. CEO Marc Rowan is set to appear at the Goldman Sachs US Financial Services Conference on December 10. Apollo’s market cap stood at about $76.3 billion.
3 December 2025
·
CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health Stock on December 2, 2025: Insulin Settlement, Analyst Targets and What’s Next for NYSE: CVS

CVS Health shares fell 1.9% to $77.62 on December 2, 2025, underperforming the S&P 500 and healthcare peers after news of a $37.76 million federal settlement over insulin-pen billing. Trading volume topped 7.7 million shares, above average. The stock remains up about 75–80% for the year but sits roughly 8–9% below its late October high. CVS did not admit liability in the settlement.
3 December 2025
···
CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group (CME) Stock News & Forecast: SEC Clearinghouse Approval, Record Volumes and Outage Fallout – December 2, 2025

CME Group reported near-record trading volumes and received SEC approval for a new securities clearing house on December 2, 2025. Shares closed at $277.49, down 0.5%. The company continues to address fallout from last week’s 10-hour trading outage. CME declared a Q4 dividend of $1.25 per share, with total distributions over the past year estimated at $10.80 per share.
3 December 2025
·
1 … 1,065 1,066 1,067 1,068 1,069 … 1,343
Go toTop